EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET Antibody-Drug Conjugate, in Patients with MET-Overexpressing NSCLC.

Details

Language :

English

ISSN :

15560864

Volume :

18

Issue :

11

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

173323730

Full Text :

https://doi.org/10.1016/j.jtho.2023.09.1136